Matteo Conti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Matteo Conti has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Mariangela Pierantozzi
Neurology Unit, Department of Systems Medicine University of Rome “Tor Vergata” Rome Italy
6 shared publications- Tommaso Schirinzi
Unit of Neurology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
5 shared publications - Alessandro Stefani
Neurology Unit, Department of Systems Medicine University of Rome “Tor Vergata” Rome Italy
4 shared publications - Diego Centonze
Department of Systems Medicine University of Rome “Tor Vergata” Rome Italy
4 shared publications Francesca Di Giuliano
Neuroradiology Unit, Department of Biomedicine and Prevention University of Rome “Tor Vergata” Rome Italy
4 shared publicationsValerio Ferrari
Neurology Unit, Department of Systems Medicine University of Rome “Tor Vergata” Rome Italy
4 shared publications
Latest Publications
- 4 October 2026
- Published by Wiley in Movement Disorders Clinical Practice
Effect of Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion on Parkinson's Disease–Related Pain: A 6‐Month Real‐World Longitudinal Study
Background: Foslevodopa/foscarbidopa (LDp/CDp) infusion may reduce PD‐related pain; however, its effects on different pain manifestations remain unclear. Objective: The aim was to evaluate longitudinal changes in overall and domain‐specific PD‐related pain after LDp/CDp infusion. Methods: Twenty‐six patients with advanced PD initiating LDp/CDp infusion underwent evaluation at baseline (T0) and 6 months (T1). Pain was assessed using the King's Parkinson's Disease Pain Scale (KPPS). Secondary outcomes included motor complications, quality of life (QoL), dopaminergic treatment burden, and pain–motor correlations. Results: At T1, KPPS total score decreased (9.6 ± 6.5 vs. 2.7 ± 4.7, P < 0.001), with improvements in chronic ( P = 0.01), fluctuation‐related ( P < 0.001), and nocturnal ( P < 0.001) pain. Motor complications reduced ( P < 0.001), and fluctuation‐related pain reduction correlated with motor complication changes (ρ = 0.46, P = 0.04). QoL improved ( P = 0.006), whereas dopaminergic treatment burden was unchanged. Conclusions: LDp/CDp infusion improved PD‐related pain, particularly chronic, fluctuation‐related, and nocturnal pain, with a parallel improvement in QoL, suggesting benefits beyond motor complication management.
- 4 October 2026
- Published by Wiley in Movement Disorders Clinical Practice
Effect of Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion on Parkinson's Disease–Related Pain: A 6‐Month Real‐World Longitudinal Study
Background: Foslevodopa/foscarbidopa (LDp/CDp) infusion may reduce PD‐related pain; however, its effects on different pain manifestations remain unclear. Objective: The aim was to evaluate longitudinal changes in overall and domain‐specific PD‐related pain after LDp/CDp infusion. Methods: Twenty‐six patients with advanced PD initiating LDp/CDp infusion underwent evaluation at baseline (T0) and 6 months (T1). Pain was assessed using the King's Parkinson's Disease Pain Scale (KPPS). Secondary outcomes included motor complications, quality of life (QoL), dopaminergic treatment burden, and pain–motor correlations. Results: At T1, KPPS total score decreased (9.6 ± 6.5 vs. 2.7 ± 4.7, P < 0.001), with improvements in chronic ( P = 0.01), fluctuation‐related ( P < 0.001), and nocturnal ( P < 0.001) pain. Motor complications reduced ( P < 0.001), and fluctuation‐related pain reduction correlated with motor complication changes (ρ = 0.46, P = 0.04). QoL improved ( P = 0.006), whereas dopaminergic treatment burden was unchanged. Conclusions: LDp/CDp infusion improved PD‐related pain, particularly chronic, fluctuation‐related, and nocturnal pain, with a parallel improvement in QoL, suggesting benefits beyond motor complication management.
- 9 September 2026
- Published by Wiley in Movement Disorders Clinical Practice
Lipid‐Related Metabolic Dysregulation Affects Survival in Idiopathic Normal Pressure Hydrocephalus
Background: Idiopathic normal pressure hydrocephalus (iNPH) is associated with increased mortality and vascular‐metabolic comorbidity, but prognostic biomarkers are lacking. Objectives: To assess the triglycerides/high‐density lipoprotein cholesterol (TG/HDL‐C) ratio, an insulin resistance (IR) marker, and its associations with MRI glymphatic markers and mortality in iNPH. Methods: We conducted a dual‐center longitudinal study including 67 iNPH patients and 37 matched controls. Baseline lipid profiles were assessed, enlarged perivascular spaces (EPVS) were rated on 3 T MRI in a subgroup, differences were tested by ANCOVA, and mortality associations by adjusted Cox models. Results: iNPH patients showed higher triglycerides and TG/HDL‐C and lower HDL‐C. High‐grade centrum semiovale (CSO)‐EPVS were associated with higher TG/HDL‐C. TG/HDL‐C showed the strongest mortality association. A model combining TG/HDL‐C with CSO‐EPVS showed the best fit, suggesting synergy. Conclusions: iNPH exhibits a lipid profile associated with IR linked to glymphatic alterations and mortality. Moreover, despite requiring large‐scale validation, combined‐marker models are promising.
- 9 September 2026
- Published by Wiley in Movement Disorders Clinical Practice
Lipid‐Related Metabolic Dysregulation Affects Survival in Idiopathic Normal Pressure Hydrocephalus
Background: Idiopathic normal pressure hydrocephalus (iNPH) is associated with increased mortality and vascular‐metabolic comorbidity, but prognostic biomarkers are lacking. Objectives: To assess the triglycerides/high‐density lipoprotein cholesterol (TG/HDL‐C) ratio, an insulin resistance (IR) marker, and its associations with MRI glymphatic markers and mortality in iNPH. Methods: We conducted a dual‐center longitudinal study including 67 iNPH patients and 37 matched controls. Baseline lipid profiles were assessed, enlarged perivascular spaces (EPVS) were rated on 3 T MRI in a subgroup, differences were tested by ANCOVA, and mortality associations by adjusted Cox models. Results: iNPH patients showed higher triglycerides and TG/HDL‐C and lower HDL‐C. High‐grade centrum semiovale (CSO)‐EPVS were associated with higher TG/HDL‐C. TG/HDL‐C showed the strongest mortality association. A model combining TG/HDL‐C with CSO‐EPVS showed the best fit, suggesting synergy. Conclusions: iNPH exhibits a lipid profile associated with IR linked to glymphatic alterations and mortality. Moreover, despite requiring large‐scale validation, combined‐marker models are promising.
- Open Access
- 19 August 2026
- Published by Wiley in Annals of Clinical and Translational Neurology
CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis
Objective: Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct cerebrospinal fluid inflammatory profiles and whether cytokine‐network features provide information beyond single‐mediator levels. Methods: In this prospective observational cohort study, baseline cerebrospinal fluid cytokine and chemokine profiling was performed in 346 RRMS patients, 61 primary progressive multiple sclerosis (PPMS) patients, and 196 neurological controls without inflammatory or neurodegenerative central nervous system disease. After 2‐year clinical and MRI follow‐up, 37 RRMS patients with clinical relapse and/or MRI activity were excluded, leaving 309 relapse‐free and MRI‐stable RRMS patients classified as stable RRMS ( n = 241) or RRMS with PIRMA ( n = 68). Cytokines were analyzed using two‐part hurdle models, cytokine interactomes, and machine‐learning classifiers. Results: Quantitative cytokine analyses distinguished multiple sclerosis from controls but showed substantial overlap across multiple sclerosis phenotypes. RRMS with PIRMA showed higher cerebrospinal fluid levels of tumor necrosis factor‐α, interleukin‐17, and RANTES than stable RRMS. Network analyses showed a more integrated cytokine interactome in RRMS with PIRMA. The network‐level model best distinguished RRMS with PIRMA from stable RRMS, with an area under the curve of 0.86, sensitivity of 77%, and specificity of 76%. Interpretation: Relapse‐independent progression in multiple sclerosis is associated with selective cytokine changes and broader reorganization of inflammatory network architecture, supporting cerebrospinal fluid cytokine interactome profiling as a translational approach to immune stratification.
- 19 August 2026
- Published by Wiley in Annals of Clinical and Translational Neurology
Open AccessCSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis
Objective: Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct cerebrospinal fluid inflammatory profiles and whether cytokine‐network features provide information beyond single‐mediator levels. Methods: In this prospective observational cohort study, baseline cerebrospinal fluid cytokine and chemokine profiling was performed in 346 RRMS patients, 61 primary progressive multiple sclerosis (PPMS) patients, and 196 neurological controls without inflammatory or neurodegenerative central nervous system disease. After 2‐year clinical and MRI follow‐up, 37 RRMS patients with clinical relapse and/or MRI activity were excluded, leaving 309 relapse‐free and MRI‐stable RRMS patients classified as stable RRMS ( n = 241) or RRMS with PIRMA ( n = 68). Cytokines were analyzed using two‐part hurdle models, cytokine interactomes, and machine‐learning classifiers. Results: Quantitative cytokine analyses distinguished multiple sclerosis from controls but showed substantial overlap across multiple sclerosis phenotypes. RRMS with PIRMA showed higher cerebrospinal fluid levels of tumor necrosis factor‐α, interleukin‐17, and RANTES than stable RRMS. Network analyses showed a more integrated cytokine interactome in RRMS with PIRMA. The network‐level model best distinguished RRMS with PIRMA from stable RRMS, with an area under the curve of 0.86, sensitivity of 77%, and specificity of 76%. Interpretation: Relapse‐independent progression in multiple sclerosis is associated with selective cytokine changes and broader reorganization of inflammatory network architecture, supporting cerebrospinal fluid cytokine interactome profiling as a translational approach to immune stratification.
- Open Access
- 27 May 2026
- Published by Wiley in Annals of Neurology
- Vol. 100 (2) , 319-333
Frequency‐ and Network‐Specific Changes in Functional Connectivity Reflect Pathophysiological Mechanisms across Parkinson's Disease Stages
Objective: Parkinson's disease (PD) is increasingly conceptualized as a disorder of large‐scale brain networks, yet whether and how frequency‐specific functional connectivity reorganizes across stages remains poorly understood. In this study, we used high‐density electroencephalography (EEG) to characterize cortico‐cortical functional connectivity across the clinical spectrum of PD. Methods: We performed high‐density EEG in a cross‐sectional cohort of 140 PD patients spanning early, intermediate, and advanced stages and 57 healthy controls. Cortico‐cortical functional connectivity was reconstructed in source space across multiple frequency bands and analyzed using network‐based statistics combined with machine‐learning models to identify stage‐dependent network alterations and evaluate their diagnostic and prognostic relevance. Results: We detected 3 distinct large‐scale networks showing divergent trajectories across disease stages. An α‐band network involving prefrontal and parieto‐temporal regions exhibited progressive hypoconnectivity and was associated with cognitive and axial impairment. A β‐band sensorimotor network showed progressive hyperconnectivity, paralleling bradykinesia severity. A high‐γ network demonstrated increased connectivity in early PD, followed by a progressive connectivity breakdown, and was inversely associated with motor complications. Multiband integration achieved near‐perfect discrimination between early PD and healthy controls and robust stratification across disease stages. Band‐specific networks also predicted clinical milestones of disease progression, with preserved α connectivity identifying patients at lower risk for cognitive and axial impairment, and stronger high‐ γ connectivity indicating reduced vulnerability to motor complications. Interpretation: Together, these results identify frequency‐specific cortical networks as markers of disease stage and clinical vulnerability and support high‐density EEG connectivity as a scalable systems‐level biomarker for diagnosis, staging, and risk stratification in PD. ANN NEUROL 2026
- 27 May 2026
- Published by Wiley in Annals of Neurology
- Vol. 100 (2) , 319-333
Open AccessFrequency‐ and Network‐Specific Changes in Functional Connectivity Reflect Pathophysiological Mechanisms across Parkinson's Disease Stages
Objective: Parkinson's disease (PD) is increasingly conceptualized as a disorder of large‐scale brain networks, yet whether and how frequency‐specific functional connectivity reorganizes across stages remains poorly understood. In this study, we used high‐density electroencephalography (EEG) to characterize cortico‐cortical functional connectivity across the clinical spectrum of PD. Methods: We performed high‐density EEG in a cross‐sectional cohort of 140 PD patients spanning early, intermediate, and advanced stages and 57 healthy controls. Cortico‐cortical functional connectivity was reconstructed in source space across multiple frequency bands and analyzed using network‐based statistics combined with machine‐learning models to identify stage‐dependent network alterations and evaluate their diagnostic and prognostic relevance. Results: We detected 3 distinct large‐scale networks showing divergent trajectories across disease stages. An α‐band network involving prefrontal and parieto‐temporal regions exhibited progressive hypoconnectivity and was associated with cognitive and axial impairment. A β‐band sensorimotor network showed progressive hyperconnectivity, paralleling bradykinesia severity. A high‐γ network demonstrated increased connectivity in early PD, followed by a progressive connectivity breakdown, and was inversely associated with motor complications. Multiband integration achieved near‐perfect discrimination between early PD and healthy controls and robust stratification across disease stages. Band‐specific networks also predicted clinical milestones of disease progression, with preserved α connectivity identifying patients at lower risk for cognitive and axial impairment, and stronger high‐ γ connectivity indicating reduced vulnerability to motor complications. Interpretation: Together, these results identify frequency‐specific cortical networks as markers of disease stage and clinical vulnerability and support high‐density EEG connectivity as a scalable systems‐level biomarker for diagnosis, staging, and risk stratification in PD. ANN NEUROL 2026
- Open Access
- 26 October 2025
- Published by Elsevier in Brain Stimulation
- Vol. 18 (6) , 1966-1977
Anodal M1 tDCS shapes frequency-specific functional connectivity and network topology in Parkinson's disease
- 26 October 2025
- Published by Elsevier in Brain Stimulation
- Vol. 18 (6) , 1966-1977
Open AccessAnodal M1 tDCS shapes frequency-specific functional connectivity and network topology in Parkinson's disease
- 29 November 2024
- Published by Wiley in Movement Disorders
- Vol. 40 (2) , 254-265
Cortical Functional Connectivity Changes in the Body‐First and Brain‐First Subtypes of Parkinson's Disease
Background: Rapid eye movement (REM) sleep behavior disorder (RBD) may precede motor symptoms in Parkinson's disease (PD) by years. According to a recent hypothesis, premotor RBD (pRBD) is a marker of the PD body‐first subtype, where synucleinopathy originates from the peripheral autonomic nervous system. Conversely, in the brain‐first subtype, pathology would arise in the brain. Functional connectivity (FC) could provide additional insight into the neurodegenerative process of these putative PD subtypes.Objectives: We aim to analyze the possible FC differences between early‐stage PD patients with (PDpRBD+) and without (PDpRBD−) pRBD using high‐density electroencephalography (EEG).Methods: We enrolled 28 PDpRBD+, 35 PDpRBD−, and 35 healthy controls (HC). Data were recorded with a 64‐channel EEG system, and a source‐reconstruction method was used to identify brain‐region activity. FC was calculated using the weighted phase‐lag index in θ, α, β, and low‐γ bands. Statistical analysis was conducted using network‐based statistic.Results: We found a significant trend of decreased α‐FC across PDpRBD+, PDpRBD−, and HC, mainly in prefrontal and temporal areas. The altered α‐FC correlated with Montreal Cognitive Assessment scores in PDpRBD+ and, to a lesser extent, PDpRBD− and with gait/postural disturbances in PDpRBD+ patients only. PDpRBD+ and PDpRBD− had similarly increased FC than HC in a β band network, predominantly involving sensorimotor and limbic areas. The increased β network FC was related to bradykinesia severity in both PD subgroups.Conclusions: Compared to PDpRBD− (brain‐first subtype), PDpRBD+ group (body‐first subtype) demonstrates specific EEG‐FC dysfunctions in the α band, which may reflect early involvement of the cholinergic ascending system. © 2024 International Parkinson and Movement Disorder Society.
- 29 November 2024
- Published by Wiley in Movement Disorders
- Vol. 40 (2) , 254-265
Cortical Functional Connectivity Changes in the Body‐First and Brain‐First Subtypes of Parkinson's Disease
Background: Rapid eye movement (REM) sleep behavior disorder (RBD) may precede motor symptoms in Parkinson's disease (PD) by years. According to a recent hypothesis, premotor RBD (pRBD) is a marker of the PD body‐first subtype, where synucleinopathy originates from the peripheral autonomic nervous system. Conversely, in the brain‐first subtype, pathology would arise in the brain. Functional connectivity (FC) could provide additional insight into the neurodegenerative process of these putative PD subtypes.Objectives: We aim to analyze the possible FC differences between early‐stage PD patients with (PDpRBD+) and without (PDpRBD−) pRBD using high‐density electroencephalography (EEG).Methods: We enrolled 28 PDpRBD+, 35 PDpRBD−, and 35 healthy controls (HC). Data were recorded with a 64‐channel EEG system, and a source‐reconstruction method was used to identify brain‐region activity. FC was calculated using the weighted phase‐lag index in θ, α, β, and low‐γ bands. Statistical analysis was conducted using network‐based statistic.Results: We found a significant trend of decreased α‐FC across PDpRBD+, PDpRBD−, and HC, mainly in prefrontal and temporal areas. The altered α‐FC correlated with Montreal Cognitive Assessment scores in PDpRBD+ and, to a lesser extent, PDpRBD− and with gait/postural disturbances in PDpRBD+ patients only. PDpRBD+ and PDpRBD− had similarly increased FC than HC in a β band network, predominantly involving sensorimotor and limbic areas. The increased β network FC was related to bradykinesia severity in both PD subgroups.Conclusions: Compared to PDpRBD− (brain‐first subtype), PDpRBD+ group (body‐first subtype) demonstrates specific EEG‐FC dysfunctions in the α band, which may reflect early involvement of the cholinergic ascending system. © 2024 International Parkinson and Movement Disorder Society.
- 20 October 2023
- Published by Wiley in Movement Disorders
- Vol. 38 (12) , 2197-2208
Band‐Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates
Background: Functional connectivity (FC) has shown promising results in assessing the pathophysiology and identifying early biomarkers of neurodegenerative disorders, such as Parkinson's disease (PD).Objectives: In this study, we aimed to assess possible resting‐state FC abnormalities in early‐stage PD patients using high‐density electroencephalography (EEG) and to detect their clinical relationship with motor and non‐motor PD symptoms.Methods: We enrolled 26 early‐stage levodopa naïve PD patients and a group of 20 healthy controls (HC). Data were recorded with 64‐channels EEG system and a source‐reconstruction method was used to identify brain‐region activity. FC was calculated using the weighted phase‐lag index in θ, α, and β bands. Additionally, we quantified the unbalancing between β and lower frequencies through a novel index (β‐functional ratio [FR]). Statistical analysis was conducted using a network‐based statistical approach.Results: PD patients showed hypoconnected networks in θ and α band, involving prefrontal‐limbic‐temporal and frontoparietal areas, respectively, and a hyperconnected network in the β frequency band, involving sensorimotor‐frontal areas. The θ FC network was negatively related to Non‐Motor Symptoms Scale scores and α FC to the Movement Disorder Society‐Sponsored Revision of the Unified Parkinson's Disease Rating Scale part III gait subscore, whereas β FC and β‐FR network were positively linked to the bradykinesia subscore. Changes in θ FC and β‐FR showed substantial reliability and high accuracy, precision, sensitivity, and specificity in discriminating PD and HC.Conclusions: Frequency‐specific FC changes in PD likely reflect the dysfunction of distinct cortical networks, which occur from the early stage of the disease. These abnormalities are involved in the pathophysiology of specific motor and non‐motor PD symptoms, including gait, bradykinesia, mood, and cognition. © 2023 International Parkinson and Movement Disorder Society.
- 20 October 2023
- Published by Wiley in Movement Disorders
- Vol. 38 (12) , 2197-2208
Band‐Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates
Background: Functional connectivity (FC) has shown promising results in assessing the pathophysiology and identifying early biomarkers of neurodegenerative disorders, such as Parkinson's disease (PD).Objectives: In this study, we aimed to assess possible resting‐state FC abnormalities in early‐stage PD patients using high‐density electroencephalography (EEG) and to detect their clinical relationship with motor and non‐motor PD symptoms.Methods: We enrolled 26 early‐stage levodopa naïve PD patients and a group of 20 healthy controls (HC). Data were recorded with 64‐channels EEG system and a source‐reconstruction method was used to identify brain‐region activity. FC was calculated using the weighted phase‐lag index in θ, α, and β bands. Additionally, we quantified the unbalancing between β and lower frequencies through a novel index (β‐functional ratio [FR]). Statistical analysis was conducted using a network‐based statistical approach.Results: PD patients showed hypoconnected networks in θ and α band, involving prefrontal‐limbic‐temporal and frontoparietal areas, respectively, and a hyperconnected network in the β frequency band, involving sensorimotor‐frontal areas. The θ FC network was negatively related to Non‐Motor Symptoms Scale scores and α FC to the Movement Disorder Society‐Sponsored Revision of the Unified Parkinson's Disease Rating Scale part III gait subscore, whereas β FC and β‐FR network were positively linked to the bradykinesia subscore. Changes in θ FC and β‐FR showed substantial reliability and high accuracy, precision, sensitivity, and specificity in discriminating PD and HC.Conclusions: Frequency‐specific FC changes in PD likely reflect the dysfunction of distinct cortical networks, which occur from the early stage of the disease. These abnormalities are involved in the pathophysiology of specific motor and non‐motor PD symptoms, including gait, bradykinesia, mood, and cognition. © 2023 International Parkinson and Movement Disorder Society.